Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $14

Benzinga · 1d ago
Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $13 to $14.